Cross-cultural adaptation of the simple Chinese version of the medication adherence reasons scale in patients undergoing adjuvant endocrine therapy for breast cancer by Lei Xu, Ping Li, Yan Hu, Weijie Xing, Jiajia Qiu, Xiaoju Zhang, Lingying Jia, Feng Jing, Ye Liu, Lili Li, Chunyang Lu

Subjects: Get full text

Management of Ductal Carcinoma In Situ: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline by Muriel Brackstone, Lisa Durocher-Allen, Nadia Califaretti, Andrea Eisen, Sarah Knowles, Abeer Salim, Taude Plexman, C. Anne Koch

Subjects: Get full text

Comprehensive review of breast cancer risk factors, diagnosis, screening, and treatment methods by Nurjamal Hoque, Ananta Choudhury, Dhiraj Baishya, Himangshu Deka

Subjects: Get full text

First-line endocrine therapy combined with CDK 4/6 inhibitor in disseminated carcinomatosis of bone marrow (DCBM) luminal breast cancer: a case report by Eko Adhi Pangarsa, Putri Dwi Astuti, Daniel Rizky, Kevin Tandarto, Budi Setiawan, Andreas Agung Winarno, Damai Santosa, Catharina Suharti

Subjects: Get full text

Safety of Abemaciclib in Indian Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced and/or Metastatic Breast Cancer: A Multi... by Dinesh Chandra Doval, Tanveer Maksud, Rajnish Nagarkar, Satheesh Chiradoni Thunagappa, Rakesh Taran, Saurabh Prasad, Anoop T. Manoharan, Minish Jain, Dhruv Mehta, Prabrajya Narayan Mohapatra, Sachin Gupta, Kritarth Naman Singh, Aarohan Pruthi, Rohit Arora

Subjects: Get full text

Bone health management in endocrine-treated patients with prostate cancer: a summary of evidence by Luo Chen, Han Shuang, Wu Qingjian, Zhu Jingzhen, Zheng Ji, Chen Yu

Subjects: Get full text

Cardiovascular and Metabolic Adverse Events of Endocrine Therapies in Women with Breast Cancer: A Disproportionality Analysis of Reports in the FDA Adverse Event Reporting System by Shaimaa Elshafie, Lorenzo Villa‐Zapata, Randall L. Tackett, Iman Y. Zaghloul, Henry N. Young

Subjects: Get full text

Research advances in estrogen receptor low positive early breast cancer by JIN Yizi, LIN Mingxi, ZENG Cheng, GUO Qing, ZHANG Jian

Subjects: “…|estrogen receptor|er-low positive|breast cancer|endocrine therapy|targeted therapy|antibody-drug conjugates…”
Get full text

First-Line (1L) Treatment Decision Patterns and Survival of Hormone Receptor (HR)-Positive/HER2-Negative Advanced Breast Cancer (ABC) Patients in a Latin American (LATAM) Public In... by Guillermo Valencia, Patricia Rioja, Miguel Chirito, Olenka Peralta, Jorge Sánchez, Connie Rabanal, Raúl Mantilla, Zaida Morante, Hugo Fuentes, Carlos Castaneda, Tatiana Vidaurre, Cristian Pacheco, Silvia Neciosup, Henry L. Gomez

Subjects: Get full text

Endocrine treatment mechanisms in triple-positive breast cancer: from targeted therapies to advances in precision medicine by Xiu Yang, Daxin Yang, Xue Qi, Xiujuan Luo, Guangmei Zhang

Subjects: Get full text

Annotation-free deep learning algorithm trained on hematoxylin & eosin images predicts epithelial-to-mesenchymal transition phenotype and endocrine response in estrogen receptor-po... by Kaimin Hu, Yinan Wu, Yajing Huang, Meiqi Zhou, Yanyan Wang, Xingru Huang

Subjects: Get full text

Beliefs about medicines’ association with endocrine therapy adherence in early breast cancer survivors in Croatia by Okroša Ana Dugonjić, Silovski Tajana, Plavetić Natalija Dedić, Silovski Hrvoje, Kovačić Ana, Mucalo Iva

Subjects: Get full text

Adherence to adjuvant endocrine therapy after breast cancer in Sweden – a nationwide cohort study in 1-, 3- and 5-year survivors with a focus on regional differences by Anna De Jong, Anna Von Wachenfeldt, Lennarth Nyström, Anne Andersson

Subjects: Get full text

Neratinib enhances the efficacy of CDK4/6 inhibitor plus endocrine therapy in HR+/HER2-low breast cancer cell line ZR-75-1 via hsa-miR-23a-5p by Liushan Chen, Lingling Ye, Yuqi Liang, Wei Luo, Qian Zuo, Ping Huang, Yuyu Hu, Yan Dai, Yingchao Wu, Qianqian Guo, Qianjun Chen

Subjects: Get full text